July 2, 2018
The UCI dismisses case against Chris Froome over salbutamol anti-doping
The UCI has announced it is closing the anti-doping case against Chris Froome just a day after ASO announce they will ban the Team Sky rider from the 2018 Tour de France.
Chris Froome was informed back in Septmeber 2017 that he had produced an adverse analystical finding for the anti-asthama drug Salbutamol after the 17th stage of the Vuelta.
Chris Froome tweeted his relief at the development:
Grateful and relieved to finally put this chapter behind me, it has been an emotional 9 months. Thank you to all of those who have supported and believed in me throughout. pic.twitter.com/OGzsg83Gjj— Chris Froome (@chrisfroome) July 2, 2018
More to come...